This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testin
English, , 826kb
The Database on Research into the Safety of Manufactured Nanomaterials (the Database) develops a global resource, which identifies research projects that address human health and environmental safety issues associated with manufactured nanomaterials.
English, , 4,506kb
This report, Applications of Complexity: Science for Public Policy: New Tools for Finding Unanticipated Consequences and Unrealised Opportunities, is a product of the Global Science Forum.
This publication assesses the current status of Mexico's innovation system and policies, and identifies where and how the government should focus its efforts to improve the country’s innovation capabilities.
This publication assesses the current status of Korea’s innovation system and policies, and identifies where and how the government should focus its efforts to improve the country’s innovation capabilities.
This report assesses the current status of Korea’s innovation system and policies, and identifies where and how the government should focus its efforts to improve the country’s innovation capabilities. It finds that Korea has one of the highest rates of spending on R&D in the world, much of which is performed by private firms. It also has a highly educated labour force – as signalled by its impressive PISA performance and exceptionally high rates of tertiary level graduation – with a strong interest in science and technology.
However, a number of bottlenecks persist that hamper Korea’s economic convergence with the leading OECD economies. These include a relatively weak SME sector and weak performance in services, as well as lagging capacities to conduct leading-edge research in many areas. Furthermore, Korea faces numerous threats in the mid term, notably increased levels of competition from China and other newly-industrialising economies, the lowest fertility rate in the OECD and an ageing society, and a continuing high dependency on imports of natural resources, particularly hydrocarbons. In the shorter term, the economic crisis offers its own challenges, with the need for some policy adjustments to deal with expected falls in business investment in R&D and growing levels of unemployment among the highly skilled.
English, , 4,583kb
This document is the report of the OECD Workshop on Exposure Assessment and Exposure Mitigation, which was held on 20 October 2008, in Frankfurt, Germany. This report includes a summary of the plenary presentations as w
English, , 288kb
This document should be seen as a component of the overall work of the programme on the safety of manufactured nanomaterials, which is been developed by OECD’s WPMN.
English, , 2,471kb
This report provides practical recommendations for facilitating an efficacious dialogue with society on scientific issues.
English, , 2,570kb
The 2009 edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.